{"id":1366,"date":"2026-08-14T11:54:07","date_gmt":"2026-08-14T08:54:07","guid":{"rendered":"https:\/\/life-peptide.com\/?page_id=1366"},"modified":"2026-08-14T14:22:40","modified_gmt":"2026-08-14T11:22:40","slug":"cjc-1295-dac-vs-no-dac","status":"publish","type":"page","link":"https:\/\/life-peptide.com\/ro\/cjc-1295-dac-vs-no-dac\/","title":{"rendered":"CJC-1295 DAC vs f\u0103r\u0103 DAC: care este diferen\u021ba?"},"content":{"rendered":"<h1 class=\"wp-block-heading\">CJC-1295 DAC vs f\u0103r\u0103 DAC: care este diferen\u021ba?<\/h1>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-with-dac\/\" data-type=\"product\" data-id=\"1274\">CJC-1295 cu DAC<\/a> \u0219i <a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-fara-dac\/\" data-type=\"product\" data-id=\"325\">CJC-1295 f\u0103r\u0103 DAC<\/a> sunt deseori prezentate ca dou\u0103 versiuni ale aceluia\u0219i peptid de cercetare. Ele ac\u021bioneaz\u0103 pe aceea\u0219i cale general\u0103, dar nu sunt interschimbabile.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Diferen\u021ba central\u0103 este <strong>durat\u0103<\/strong>. CJC-1295 cu DAC este conceput pentru a se lega de albumin\u0103 \u0219i a r\u0103m\u00e2ne activ timp de c\u00e2teva zile. Produsul v\u00e2ndut \u00een mod obi\u0219nuit ca CJC-1295 f\u0103r\u0103 DAC nu are aceast\u0103 component\u0103 de legare la albumin\u0103 \u0219i este utilizat pentru a studia un semnal GHRH mai scurt, de tip impuls.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Exist\u0103, de asemenea, un detaliu important de denumire: \u00een literatura \u0219tiin\u021bific\u0103, <strong>CJC-1295 se refer\u0103 de obicei la compusul care con\u021bine DAC<\/strong>. \u201cCJC-1295 no DAC\u201d este denumirea comercial\u0103 uzual\u0103 pentru peptida cu ac\u021biune mai scurt\u0103 cunoscut\u0103 mai precis sub denumirea de <strong>GRF modificat (1-29)<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">CJC-1295 DAC vs F\u0103r\u0103 DAC dintr-o privire<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Caracteristic\u0103<\/th><th><a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-with-dac\/\" data-type=\"product\" data-id=\"1274\">CJC-1295 cu DAC<\/a><\/th><th><a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-fara-dac\/\" data-type=\"product\" data-id=\"325\">CJC-1295 f\u0103r\u0103 DAC<\/a><\/th><\/tr><\/thead><tbody><tr><td>Nume mai precis<\/td><td>CJC-1295 \/ DAC:GRF<\/td><td>GRF modificat (1-29)<\/td><\/tr><tr><td>Familie de peptide<\/td><td>Analog GHRH<\/td><td>Analog GHRH<\/td><\/tr><tr><td>Cale principal\u0103<\/td><td>Semnalizarea receptorului GHRH \u2192 GH \u2192 IGF-1<\/td><td>Semnalizarea receptorului GHRH \u2192 GH \u2192 IGF-1<\/td><\/tr><tr><td>Legarea de albumin\u0103<\/td><td>Da<\/td><td>Nu<\/td><\/tr><tr><td>Profil Signal<\/td><td>Expunere prelungit\u0103<\/td><td>Expunere mai scurt\u0103, de tip puls<\/td><\/tr><tr><td>Timpul de \u00eenjum\u0103t\u0103\u021bire uman raportat<\/td><td>Aproximativ 5,8\u20138,1 zile<\/td><td>Mult mai scurt; nestabilit \u00een acelea\u0219i studii clinice<\/td><\/tr><tr><td>Domeniu tipic de cercetare<\/td><td>Stimulare sus\u021binut\u0103 a axei GH<\/td><td>Semnalizarea GHRH tranzitorie sau pulsatil\u0103<\/td><\/tr><tr><td>Produs LIFE<\/td><td><strong>CJC-1295 cu DAC, 2 mg<\/strong><\/td><td><strong>CJC-1295 f\u0103r\u0103 DAC, 5 mg<\/strong><\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00cen termeni simpli:<\/strong> DAC este op\u021biunea cu ac\u021biune prelungit\u0103, \u00een timp ce f\u0103r\u0103 DAC este op\u021biunea cu ac\u021biune scurt\u0103. Niciuna nu este universal mai bun\u0103 \u2013 alegerea potrivit\u0103 depinde de modelul de cercetare.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Exploreaz\u0103 compu\u0219ii:<\/strong> <a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-with-dac\/\" data-type=\"product\" data-id=\"1274\">CJC-1295 cu DAC<\/a> \u00b7 <a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-fara-dac\/\" data-type=\"product\" data-id=\"325\">CJC-1295 f\u0103r\u0103 DAC<\/a><\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Ce \u00eenseamn\u0103 DAC \u00een CJC-1295?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">DAC vine de la <strong>Complex de afinitate pentru medicamente<\/strong>. Este adi\u021bia structural\u0103 care permite CJC-1295 s\u0103 formeze o leg\u0103tur\u0103 stabil\u0103 cu albumina, o protein\u0103 cu via\u021b\u0103 lung\u0103 care circul\u0103 \u00een s\u00e2nge.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">F\u0103r\u0103 aceast\u0103 caracteristic\u0103, peptidele mici sunt, \u00een general, eliminate \u0219i descompuse relativ rapid. Legarea de albumin\u0103 protejeaz\u0103 moleculele care con\u021bin DAC \u00eempotriva \u00eendep\u0103rt\u0103rii rapide \u0219i le prelunge\u0219te considerabil timpul de expunere.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Aceasta nu este doar o mic\u0103 modificare a intensit\u0103\u021bii. Ea schimb\u0103 profilul farmacocinetic al compusului \u0219i, prin urmare, tipul de \u00eentrebare de cercetare la care acesta poate r\u0103spunde.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lucrarea preclinic\u0103 original\u0103 a identificat CJC-1295 ca un analog GHRH de lung\u0103 durat\u0103 prin acest design de legare de albumin\u0103. \u00centr-un studiu ulterior care a implicat adul\u021bi s\u0103n\u0103to\u0219i, timpul s\u0103u de injum\u0103t\u0103\u021bire estimat a fost <strong>de la 5,8 la 8,1 zile<\/strong>, cu valori crescute ale GH \u0219i IGF-1 care persist\u0103 mult dup\u0103 expunerea ini\u021bial\u0103.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Ce este CJC-1295 f\u0103r\u0103 DAC?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Produsul numit pe scar\u0103 larg\u0103 <strong>CJC-1295 f\u0103r\u0103 DAC<\/strong> este un fragment modificat de 29 de aminoacizi al hormonului de eliberare a hormonului de cre\u0219tere. Ac Acesta p\u0103streaz\u0103 substitu\u021biile menite s\u0103 \u00eembun\u0103t\u0103\u021beasc\u0103 stabilitatea comparativ cu GHRH-ul nativ, dar nu include extensia DAC de legare la albumin\u0103.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Din acest motiv, are o durat\u0103 de ac\u021biune mult mai scurt\u0103 dec\u00e2t CJC-1295 cu DAC. Profilul s\u0103u de cercetare este descris \u00een mod obi\u0219nuit ca <strong>sub form de puls<\/strong> mai degrab\u0103 dec\u00e2t sus\u021binut.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Denumirea \u0219tiin\u021bific\u0103 mai exact\u0103 este <strong>GRF modificat (1-29)<\/strong>. Cu toate acestea, \u201cCJC-1295 no DAC\u201d a devenit denumirea pe care majoritatea cercet\u0103torilor \u0219i cump\u0103r\u0103torilor o folosesc atunci c\u00e2nd caut\u0103 produsul, a\u0219a c\u0103 ambii termeni sunt utili atunci c\u00e2nd se compar\u0103 compu\u0219ii.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Ambele forme func\u021bioneaz\u0103 prin aceea\u0219i cale?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">\u00cen linii mari, da. Ambele sunt analogi ai GHRH \u0219i activeaz\u0103 receptorul hormonului de eliberare a hormonului de cre\u0219tere la nivel hipofizar. Aceasta stimuleaz\u0103 eliberarea endogen\u0103 de GH, care poate influen\u021ba ulterior semnalizarea IGF-1.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Diferen\u021ba const\u0103 \u00een principal \u00een <strong>profilul temporal al stimul\u0103rii receptorului<\/strong>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>CJC-1295 cu DAC:<\/strong> expunere sistemic\u0103 prelungit\u0103 \u0219i stimulare sus\u021binut\u0103 a axei GH.<\/li>\n\n\n\n<li><strong>CJC-1295 f\u0103r\u0103 DAC:<\/strong> stimulare mai scurt\u0103 a receptorului GHRH, potrivit\u0103 pentru cercetarea axat\u0103 pe semnalizarea tranzitorie.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Este ademenitor s\u0103 reducem acest lucru la \u201cGH constant versus pulsatil\u201d, dar acest lucru este pu\u021bin prea simplist. Cercet\u0103rile pe oameni au ar\u0103tat c\u0103 pulsatilitatea fiziologic\u0103 a GH ar putea persistat \u00een timpul stimul\u0103rii continue cu CJC-1295 con\u021bin\u00e2nd DAC.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">DAC extinde expunerea; o face <strong>nu neap\u0103rat s\u0103 aplatizeze fiecare impuls GH<\/strong> \u00eentr-un semnal complet constant.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Care este mai bun: CJC-1295 DAC sau f\u0103r\u0103 DAC?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Niciuna dintre forme nu este \u00een mod inherent mai bun\u0103. Ele sunt concepute pentru modele experimentale diferite.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">CJC-1295 cu DAC se poate potrivi pentru cercet\u0103ri axate pe:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Stimularea prelungit\u0103 a receptorului GHRH<\/li>\n\n\n\n<li>R\u0103spunsuri sus\u021binute ale GH \u0219i IGF-1<\/li>\n\n\n\n<li>Tehnologia peptidelor de legare a albuminei<\/li>\n\n\n\n<li>Ferestre de observa\u021bie farmacocinetic\u0103 mai lungi<\/li>\n\n\n\n<li>Efecte cumulative \u00een urma expunerii repetate<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">CJC-1295 f\u0103r\u0103 DAC se poate potrivi pentru cercet\u0103ri axate pe:<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Semnalizarea GHRH de durat\u0103 mai scurt\u0103<\/li>\n\n\n\n<li>Designuri experimentale tranzitorii sau orientate spre impulsuri<\/li>\n\n\n\n<li>Rela\u021biile de temporizare dintre GHRH \u0219i alte c\u0103i de semnalizare<\/li>\n\n\n\n<li>Modele \u00een care expunerea prelungit\u0103 la compu\u0219i lega\u021bi de albumin\u0103 este nedorit\u0103<\/li>\n\n\n\n<li>Compara\u021bia cu al\u021bi secretagogi de GH cu ac\u021biune scurt\u0103<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Prin urmare, decizia practic\u0103 de cump\u0103rare ar trebui s\u0103 urmeze protocolul de laborator inten\u021bionat \u2013 nu presupunerea c\u0103 o ac\u021biune mai lung\u0103 \u00eenseamn\u0103 automat un compus mai puternic sau superior.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Este CJC-1295 f\u0103r\u0103 DAC cu adev\u0103rat CJC-1295?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Aici terminologia de produs \u0219i cea \u0219tiin\u021bific\u0103 se despart.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Strict vorbind, numele <strong>CJC-1295<\/strong> a fost atribuit moleculei cu ac\u021biune prelungit\u0103, care con\u021bine DAC. Fragmentul GHRH tetrasubstituit cu ac\u021biune scurt\u0103, f\u0103r\u0103 extensia DAC, este <strong>GRF modificat (1-29)<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cu toate acestea, \u201cCJC-1295 f\u0103r\u0103 DAC\u201d este acum termenul comercial de c\u0103utare consacrat. Informa\u021biile credibile despre produse ar trebui s\u0103 clarifice aceast\u0103 rela\u021bie, \u00een loc s\u0103 ignore problema denumirii:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>CJC-1295 cu DAC<\/strong> este compusul original cu ac\u021biune prelungit\u0103, care leag\u0103 albumina.<\/li>\n\n\n\n<li><strong>CJC-1295 f\u0103r\u0103 DAC<\/strong> este denumirea de pia\u021b\u0103 utilizat\u0103 \u00een mod obi\u0219nuit pentru Modificat GRF (1-29).<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Aceast\u0103 distinc\u021bie conteaz\u0103 atunci c\u00e2nd se citesc studiile. Rezultatele farmacocinetice la umane pentru CJC-1295 cu DAC nu ar trebui s\u0103 fie aplicate automat produsului f\u0103r\u0103 DAC.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">CJC-1295 versus Ipamorelin: sunt ele acela\u0219i tip de peptid\u0103?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Nu. De\u0219i ambele apar \u00een cercetarea privind hormonul de cre\u0219tere, ele activeaz\u0103 receptori diferi\u021bi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">CJC-1295 \u0219i Modified GRF (1-29) sunt <strong>agoni\u0219ti ai receptorului GHRH<\/strong>. Ipamorelin este un <strong>agonist al receptorului grelinei<\/strong>, descris \u0219i ca un agonist al receptorului secretagogului de hormon de cre\u0219tere.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Cercet\u0103torii pot investiga c\u0103ile separat sau pot examina modul \u00een care semnalele GHRH \u0219i ale receptorului de grelin\u0103 interac\u021bioneaz\u0103, dar un compus nu este pur \u0219i simplu un substitut pentru cel\u0103lalt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pentru o explica\u021bie mai detaliat\u0103, consulta\u021bi sec\u021biunea noastr\u0103 <a href=\"https:\/\/life-peptide.com\/ro\/growth-hormone-peptides-guide\/\" data-type=\"link\" data-id=\"https:\/\/life-peptide.com\/growth-hormone-peptides-guide\/\">Ghid de cercetare a peptidelor hormonului de cre\u0219tere<\/a> sau exploreaz\u0103 <a href=\"https:\/\/life-peptide.com\/ro\/product\/ipamorelin-5-mg\/\" data-type=\"product\" data-id=\"355\">Ipamorelin<\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Alegerea \u00eentre cele dou\u0103 produse de cercetare LIFE<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">LIFE furnizeaz\u0103 ambele formate pentru cercetarea de laborator \u0219i analitic\u0103.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">CJC-1295 cu DAC<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Formatul cu ac\u021biune prelungit\u0103 pentru cercetarea care implic\u0103 legarea de albumin\u0103 \u0219i semnalizarea prelungit\u0103 pe axa GHRH.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-with-dac\/\" data-type=\"product\" data-id=\"1274\">Vezi CJC-1295 cu DAC<\/a><\/strong><\/p>\n\n\n\n<h3 class=\"wp-block-heading\">CJC-1295 f\u0103r\u0103 DAC \u2014 5 mg<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Formatul de ac\u021biune scurt\u0103 Modified GRF (1-29) pentru cercetare care implic\u0103 semnalizarea tranzitorie sau orientat\u0103 spre puls a GHRH.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-fara-dac\/\" data-type=\"product\" data-id=\"325\">Vezi CJC-1295 f\u0103r\u0103 DAC<\/a><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Ambele produse sunt furnizate ca material de cercetare liofilizat, \u00eenso\u021bit de documenta\u021bia aferent\u0103 lotului. Ele sunt destinate exclusiv cercet\u0103rii de laborator \u0219i uzului analitic \u2014 nu pentru uz uman sau veterinar.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">\u00centreb\u0103ri frecvente<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Care este diferen\u021ba principal\u0103 dintre CJC-1295 cu DAC \u0219i f\u0103r\u0103 DAC?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Diferen\u021ba principal\u0103 const\u0103 \u00een legarea de albumin\u0103 \u0219i durat\u0103. CJC-1295 care con\u021bine DAC se leag\u0103 de albumin\u0103 \u0219i are un timp de \u00eenjum\u0103t\u0103\u021bire raportat de c\u00e2teva zile. CJC-1295 f\u0103r\u0103 DAC nu are aceast\u0103 component\u0103 de legare \u0219i produce un profil de expunere mult mai scurt.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Ce \u00eenseamn\u0103 \u201cf\u0103r\u0103 DAC\u201d?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Aceasta \u00eenseamn\u0103 c\u0103 peptida nu con\u021bine Complexul de Afinitate pentru Medicamente utilizat pentru legarea de albumin\u0103. Eliminarea acestei caracteristici \u00eel transform\u0103 dintr-un compus de cercetare cu ac\u021biune prelungit\u0103 \u00eentr-un analog GHRH cu ac\u021biune mai scurt\u0103.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Este CJC-1295 f\u0103r\u0103 DAC acela\u0219i lucru cu Modified GRF (1-29)?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Pe pia\u021ba peptidelor de cercetare, aceste denumiri se refer\u0103 \u00een mod normal la acela\u0219i compus cu ac\u021biune scurt\u0103. Modified GRF (1-29) este termenul cel mai exact din punct de vedere chimic; CJC-1295 f\u0103r\u0103 DAC este denumirea comercial\u0103 c\u0103utat\u0103 mai frecvent.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">CJC-1295 cu DAC produce doar un semnal constant de GH?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Nu chiar. DAC creeaz\u0103 o expunere prelungit\u0103, dar cercet\u0103rile publicate pe subiec\u021bi umani au descoperit c\u0103 secre\u021bia pulsatil\u0103 de GH a persistat \u00een timpul stimulo-secre\u021biei continue cu CJC-1295. \u201cCu ac\u021biune lung\u0103\u201d este mai precis dec\u00e2t a descrie r\u0103spunsul ca fiind complet plat sau constant.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Este CJC-1295 f\u0103r\u0103 DAC mai puternic dec\u00e2t CJC-1295 cu DAC?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Cele dou\u0103 nu pot fi clasificate \u00een mod semnificativ dup\u0103 cantitatea din flacon sau printr-o simpl\u0103 etichet\u0103 de \u201cmai puternic\u201d. Cea mai important\u0103 diferen\u021b\u0103 a lor o reprezint\u0103 durata \u0219i modelul expunerii. Alegerea relevant\u0103 depinde de designul experimental.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Pot rezultatele cercet\u0103rii privind CJC-1295 cu DAC s\u0103 fie aplicate la cel f\u0103r\u0103 DAC?<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Nu \u00een mod automat. Ele \u00eemp\u0103rt\u0103\u0219esc o cale central\u0103 \u00eenrudit\u0103 cu GHRH, dar farmacocinetica lor este foarte diferit\u0103. Studiile trebuie verificate cu aten\u021bie pentru a stabili ce molecul\u0103 a fost investigat\u0103 efectiv.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\">Rezumat<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">CJC-1295 cu DAC \u0219i CJC-1295 f\u0103r\u0103 DAC ac\u021bioneaz\u0103 prin calea GHRH, dar profilurile lor de expunere sunt fundamental diferite.<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Cu DAC:<\/strong> legare de albumin\u0103, timp de \u00eenjum\u0103t\u0103\u021bire de mai multe zile \u0219i semnalizare prelungit\u0103 GH\/IGF-1.<\/li>\n\n\n\n<li><strong>F\u0103r\u0103 DAC:<\/strong> f\u0103r\u0103 legare de albumin\u0103, o expunere mai scurt\u0103 \u0219i cercetare GHRH orientat\u0103 spre pulsuri.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Expresia \u201cCJC-1295 f\u0103r\u0103 DAC\u201d este cunoscut\u0103 comercial, \u00een timp ce GRF Modificat (1-29) este mai precis din punct de vedere \u0219tiin\u021bific. Pentru cump\u0103r\u0103torii care le compar\u0103, \u00eentrebarea decisiv\u0103 nu este care peptid\u0103 este \u00een general mai bun\u0103 \u2013 ci dac\u0103 modelul de cercetare necesit\u0103 <strong>semnalizare sus\u021binut\u0103 sau de scurt\u0103 durat\u0103<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Compar\u0103 formatele disponibile:<\/strong> <a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-with-dac\/\" data-type=\"product\" data-id=\"1274\">CJC-1295 cu DAC<\/a> \u00b7 <a href=\"https:\/\/life-peptide.com\/ro\/product\/cjc-1295-fara-dac\/\" data-type=\"product\" data-id=\"325\">CJC-1295 f\u0103r\u0103 DAC<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">R\u0103sfoie\u0219te toate compu\u0219ii din <a href=\"https:\/\/life-peptide.com\/ro\/category\/secretagogi-ai-hormonului-de-crestere\/\" data-type=\"product_cat\" data-id=\"21\"><strong>Categoria secretagogilor hormonului de cre\u0219tere<\/strong><\/a>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Referin\u021be<\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Jett\u00e9 L, et al. <em>Bioconjugatele de albumin\u0103 cu factorul de eliberare a hormonului de cre\u0219tere uman (hGRF)1-29 activeaz\u0103 receptorul GRF de la nivelul adenohipofizei la \u0219obolani: identificarea CJC-1295 ca analog GRF de lung\u0103 durat\u0103.<\/em> Endocrinology. 2005;146(7):3052\u20133058.<\/li>\n\n\n\n<li>Teichman SL, et al. <em>Stimularea prelungit\u0103 a secre\u021biei de hormon de cre\u0219tere \u0219i de factor de cre\u0219tere 1 asem\u0103n\u0103tor insulinei de c\u0103tre CJC-1295, un analog cu ac\u021biune prelungit\u0103 al hormonului eliberator de hormon de cre\u0219tere, la adul\u021bi s\u0103n\u0103to\u0219i.<\/em> Journal of Clinical Endocrinology &amp; Metabolism. 2006;91(3):799\u2013805.<\/li>\n\n\n\n<li>Ionescu M, Frohman LA. <em>Secre\u021bia pulsatil\u0103 a hormonului de cre\u0219tere persist\u0103 \u00een timpul stimulatoriilor continue cu CJC-1295, un analog al hormonului de eliberare a hormonului de cre\u0219tere cu ac\u021biune prelungit\u0103.<\/em> Journal of Clinical Endocrinology &amp; Metabolism. 2006;91(12):4792\u20134797.<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>","protected":false},"excerpt":{"rendered":"<p>CJC-1295 DAC vs no DAC: what is the difference? CJC-1295 with DAC and CJC-1295 no DAC are often presented as two versions of the same research peptide. They act on the same general pathway, but they are not interchangeable. The central difference is duration. CJC-1295 with DAC is designed to bind to albumin and remain [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1366","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/life-peptide.com\/ro\/wp-json\/wp\/v2\/pages\/1366","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/life-peptide.com\/ro\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/life-peptide.com\/ro\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/ro\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/life-peptide.com\/ro\/wp-json\/wp\/v2\/comments?post=1366"}],"version-history":[{"count":2,"href":"https:\/\/life-peptide.com\/ro\/wp-json\/wp\/v2\/pages\/1366\/revisions"}],"predecessor-version":[{"id":1370,"href":"https:\/\/life-peptide.com\/ro\/wp-json\/wp\/v2\/pages\/1366\/revisions\/1370"}],"wp:attachment":[{"href":"https:\/\/life-peptide.com\/ro\/wp-json\/wp\/v2\/media?parent=1366"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}